Delivery Order SPE2DB22D2211-SPE2DB25FRYBN
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, with a ceiling value of $5,400.42 and a period of performance through May 22, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250MG 30S, a prescription medication, with a ceiling value of $1,672.50 and a period of performance through June 12, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, with a firm fixed price of $2,787.50 and a performance period ending on May 29, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, with a firm fixed price of $2,529.31 and a completion date of May 22, 2025. The contract is not set aside and was awarded under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, with a firm fixed-price ceiling value of $1,114.90 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit company registered in...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,039.60, is for the delivery of Armodafinil 250 mg tablets. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,672.50 firm fixed-price delivery order is for the supply of 4567707530 ARMODAFINIL 250 MG TABLET 30S, with a performance period ending on March 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a Delivery Order (DO) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,304,142 units of Armodafinil 250 mg tablets, with a period of performance through February 19, 2025 and a ceiling value of $1,683.34. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,192,477 units of the prescription medication armodafinil 250 mg tablets. The contract has a firm fixed price of $1,672.35 and a completion date of May 9, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of Armodafinil 250 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $1,742.12 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...